Sinopharm
Update in progress1099.HK (HKSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Distribution
Sinopharm Group Co. Ltd., with its subsidiaries, buys, sells, and distributes pharmaceutical and healthcare products and medical devices in China. It operates four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. It also provides logistics, installation, maintenance, IT, consulting, and related services, and engages in manufacturing and property management. Based in Shanghai, it was founded in 2003 and is part of Sinopharm Industrial Investment.
Company score
- Sentiment
- 0.32
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.17
- Governance
- 0.06
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.06
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.19
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Loading section